Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The plaque biofilm matrix is not a single molecule or classical molecular target, but rather a complex, heterogeneous extracellular structure that surrounds bacterial communities in dental plaque[1][3][6][7]. It is composed primarily of exopolysaccharides (such as glucans and fructans produced by bacterial enzymes), extracellular DNA, proteins, lipids, and other macromolecules derived from both the resident microbiota and the host[1][3][6][7]. The matrix is essential for biofilm stability, functioning to maintain the spatial arrangement of microorganisms, protect against physical and chemical insults—including antimicrobials—and to mediate adhesion to tooth surfaces[1][2][3]. It facilitates the development of cariogenic (cavity-causing) and periodontopathogenic (gum disease–causing) communities by creating microenvironments with gradients in pH, nutrients, and oxygen[2][3]. The structure and composition of the matrix enable pathogens to persist in the oral cavity despite host defense mechanisms and therapeutic interventions[3][6]. Because it is not a specific molecular entity, the “plaque biofilm matrix” is not classified as a receptor, enzyme, or traditional druggable target, but targeting its structural components (notably exopolysaccharides and extracellular DNA) is an emerging strategy in oral disease management[1][3][6].
Disruption of exopolysaccharide network; Destabilization of matrix via enzymatic or chemical means; Reduction/neutralization of extracellular DNA (eDNA)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plaque biofilm matrix (null).